Skip to content
healthcare.dev

RenThyroid

NDC 64950-174, LEVOTHYROXINE and LIOTHYRONINE, tablet, from Genus Lifesciences.

Product NDC
64950-174
Status
Listed
Labeler
Genus Lifesciences
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/64950-174 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVOTHYROXINE76 ug/1
  • LIOTHYRONINE18 ug/1

Pharmacologic classes

Thyroxine [CS]; Triiodothyronine [CS]; l-Thyroxine [EPC]; l-Triiodothyronine [EPC]

Package NDCNDC-11Package
64950-174-0164950017401100 TABLET in 1 BOTTLE (64950-174-01)
64950-174-096495001740990 TABLET in 1 BOTTLE (64950-174-09)
64950-174-146495001741414 TABLET in 1 BOTTLE (64950-174-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0f0c1875-7706-43ec-a9ef-ad82a49e46ec

Use it

Look up 64950-174 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/64950-174 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 64950-174. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.